[CG] Endometrial hyperplasia, management

Warning

exp date isn't null, but text field is

Abstract

Please report any inaccuracies or issues with this guideline using our online form

Endometrial cancer is the most common gynaecological malignancy in the Western world and endometrial hyperplasia is its precursor. The most common presentation of endometrial hyperplasia is abnormal uterine bleeding (this includes HMB, IMB, PMB and bleeding on HRT)

Resources

Use the button below to access this resource item.

Access this resource

Last reviewed: 18 September 2017

Next review: 31 August 2022

Author(s): Dr M Hair

Approved By: Dr R Jamieson, Clinical Director